A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
The Oscar Lambret Center is a private health facility of collective interest (ESPIC). It is based on several fundamental values: A multidisciplinary approach, medical progress, and attention to the patient.
Lille, France Clinical Trial Location
Centre Oscar Lambret
3 Rue Frédéric Combemale,
59000 Lille, France